简介：
Overview
This protocol describes a method to construct rheumatoid arthritis (RA) models that closely mimic human RA, focusing on CD4 + T cells and cytokines. The use of invariant natural killer T cells (iNKT) for treatment shows promise in immunotherapy applications.
Key Study Components
Area of Science
- Immunology
- Rheumatology
- Cell Therapy
Background
- Rheumatoid arthritis is a complex autoimmune disease.
- The pathogenesis involves T cells, B cells, and innate immunity.
- Current models do not fully replicate human RA.
- iNKT cells have immunomodulatory effects beneficial for treatment.
Purpose of Study
- To develop a reliable RA model with a high success rate.
- To explore the role of immune cells in RA pathogenesis.
- To evaluate the therapeutic potential of iNKT cells.
Methods Used
- In vivo induction of iNKT cells.
- In vitro purification of iNKT cells.
- Adoptive immunotherapy techniques.
- Assessment of RA model efficacy.
Main Results
- The RA model achieved a success rate of over 93%.
- iNKT cells demonstrated significant therapeutic effects.
- The model allows for comprehensive study of RA pathogenesis.
- Simple and reproducible methodology enhances accessibility for researchers.
Conclusions
- The developed RA model is a valuable tool for research.
- iNKT cells hold promise for clinical applications in RA treatment.
- This study provides foundational data for future immunotherapy strategies.
What is the success rate of the RA model?
The RA model has a success rate of over 93%.
How are iNKT cells used in this study?
iNKT cells are induced in vivo and purified for adoptive immunotherapy.
What is the significance of this RA model?
It closely mimics human RA, allowing for better understanding of its pathogenesis.
Who conducted the study?
The study was conducted by Chen Shengde, Gao Xiang, and Zhang Jingnan from the laboratory.
What are the advantages of this methodology?
The methodology is simple to operate and easy to replicate.
What are the implications for clinical applications?
The findings support the clinical application of iNKT cells in RA treatment.
繁體中文
